- (to embed) Audio podcast interview with Mitchell Warren is online at: http://bit.ly/2RdtUzI
Mitchell Warren is Executive Director of AVAC and noted HIV prevention research advocate
(Image by CNS (Citizen News Service citizen-news.org)) Details DMCA
And yet we are far away from ending the AIDS epidemic by 2030, and are also falling short of achieving the 90-90-90 UNAIDS targets by 2020.
While there has been immense progress in the field of HIV science, we are yet to see its public health impact on the ground.
"It is not just about R&D but about R&D and D - research and development, and delivery. If you take anyone of those three letters out, we fail. Each of them is equally important. Undoubtedly, it is difficult to successfully complete the clinical study for a new product, but delivering that product to the people for whom it was designed, is harder. Whether it is the ARVs, PrEP, vaginal rings, multipurpose prevention tools like the female condom, we see a huge gap in delivery", said Mitchell Warren, Executive Director of AVAC, in an exclusive interview given to CNS onsite at the HIVR4P Conference being held in Madrid.
Every new infection of HIV could have been averted
Till to date, more than 35 million people have died of HIV-related illnesses, and another 37 million people are living with HIV worldwide. In 2017 alone there were 1.8 million new infections (87,580 in India) and 940,000 deaths (69,110 in India). Governments have promised to end AIDS by 2030.
But the new cases graph is not dipping towards that steeply enough. Why are we failing to prevent new HIV transmissions?
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).